Kevin Boyle, an experienced finance executive, has joined Cell Medica Ltd as chief financial officer to help the company execute clinical trials of its new T cell therapies for cancer. Mr Boyle has held senior finance roles at both Nasdaq-listed and private equity backed companies. He received a law degree from the University of Pennsylvania and a Bachelor of Science degree in industrial management and economics from Carnegie Mellon University, US.
Cell Medica announced the appointment on 16 February 2018.
Copyright 2018 Evernow Publishing Ltd